Showing results (21-30 of 28) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Journal of Medicinal Chemistry|February 7, 2015
Engineering potent and selective analogues of GpTx-1, a tarantula venom peptide antagonist of the Na(V)1.7 sodium channelJustin K Murray, Joseph Ligutti, Dong Liu, et al.The Journal of Biological Chemistry|June 26, 2009
Hepcidin revisited, disulfide connectivity, dynamics, and structureJohn B Jordan, Leszek Poppe, Mitsuru Haniu, et al.Bioorganic & Medicinal Chemistry Letters|June 27, 2015
Sustained inhibition of the NaV1.7 sodium channel by engineered dimers of the domain II binding peptide GpTx-1Justin K Murray, Kaustav Biswas, J Ryan Holder, et al.Journal of Medicinal Chemistry|April 17, 2008
Design and synthesis of conformationally constrained glucagon-like peptide-1 derivatives with increased plasma stability and prolonged in vivo activityLes P Miranda, Katherine A Winters, Colin V Gegg, et al.Journal of Medicinal Chemistry|March 15, 2021
Discovery of Selective Pituitary Adenylate Cyclase 1 Receptor (PAC1R) Antagonist Peptides Potent in a Maxadilan/PACAP38-Induced Increase in Blood Flow Pharmacodynamic ModelEssa Hu, Fang-Tsao Hong, Jennifer Aral, et al.Journal of Medicinal Chemistry|March 14, 2022
Targeting the Mitotic Kinesin KIF18A in Chromosomally Unstable Cancers: Hit Optimization Toward an In Vivo Chemical ProbeNuria A Tamayo, Matthew P Bourbeau, Jennifer R Allen, et al.Cancer Discovery|September 27, 2018
AMG 176, a Selective MCL1 Inhibitor, Is Effective in Hematologic Cancer Models Alone and in Combination with Established TherapiesSean Caenepeel, Sean P Brown, Brian Belmontes, et al.Journal of Medicinal Chemistry|July 14, 2026
Expanding Addressable KRAS Mutations through the Structure- and Property-Based Design of Dual-State (GDP/GTP), Reversible Pan-KRAS InhibitorsRyan P Wurz, Jennifer R Allen, John G Allen, et al.Pageof 3